Search Results
Found 1 results
510(k) Data Aggregation
(24 days)
TRADEMARK BLOOD GAS/ELECTROLYTE/GLUCOSE, LACTATE, BUN AND CREATININE CONTROL
This material is intended for use to monitor the measurements of: a. pH and pCO2 and pO2 in blood gas analyzers, - b. Na, K, Cl, Li, Ca++, and Mg++ in electrolyte analyzers, and; - c. glucose, lactate, BUN and creatinine in analyzers which measure these metabolites. The Control is provided at three clinically significant levels to make possible verification of instrument performance at different points for each analyte. This product is for In Vitro Diagnostic Use only.
Not Found
I am sorry, but the provided text is a 510(k) premarket notification letter from the FDA to Bionostics, Inc. regarding their "Blood Gas/Electrolyte/Glucose, Lactate, BUN, and Creatinine Control" product.
This document
- determines substantial equivalence for a specific in-vitro diagnostic control product.
- does not contain any information about a study, acceptance criteria, or device performance data.
- does not describe any AI/ML components.
- does not mention any details about sample sizes, ground truth establishment, or expert involvement.
Therefore, I cannot extract the requested information to fill in the table and answer the questions. The text is purely a regulatory communication.
Ask a specific question about this device
Page 1 of 1